Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 9Head & Neck 2Gastrointestinal 2Endocrine 2Dermatologic 2CNS 2Gynecologic 1Genitourinary 1Classical hematology 1

Conditions

Neuroendocrine Tumors 69Carcinoma, Neuroendocrine 26Pheochromocytoma 23Thyroid Cancer, Papillary 21Pituitary Neoplasms 21Thyroid Neoplasms 20Adrenocortical Carcinoma 18Paraganglioma 15Multiple Endocrine Neoplasia Type 1 12Sarcoma 11Neuroblastoma 11Small Cell Lung Carcinoma 10Neoplasms 10Melanoma 9Lung Neoplasms 9Carcinoid Tumor 9Adrenal Gland Neoplasms 9Adenoma, Islet Cell 9Pancreatic Neoplasms 8Gastro-enteropancreatic neuroendocrine tumor 8Carcinoma, Non-Small-Cell Lung 8Carcinoma, Medullary 8Adenocarcinoma, Follicular 8Thyroid Carcinoma, Anaplastic 7Ovarian Neoplasms 7Neoplasm Metastasis 7Cushing Syndrome 7Cholangiocarcinoma 7Central Nervous System Neoplasms 7Breast Neoplasms 7

Interventions

Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Chordoma × Endocrine × 90 days × Clear all
NCT02834013 2026-06-03

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

National Cancer Institute (NCI)

Phase 2 Active not recruiting
798 enrolled
CNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

Nasopharyngeal Carcinoma, Bile Duct Neoplasms, Carcinoma, Basal Cell, Adenocarcinoma, Bronchiolo-Alveolar, Adenocarcinoma, Mucinous, Carcinoma, Transitional Cell, Carcinosarcoma, Chordoma, Carcinoma, Adenoid Cystic, Fibroma, Gallbladder Neoplasms, Hemangiosarcoma, Mouth Neoplasms, Paget Disease, Extramammary, Paraganglioma, Paranasal Sinus Neoplasms, Parathyroid Neoplasms, Pheochromocytoma, Pseudomyxoma Peritonei, Somatostatinoma, Thyroid Neoplasms, Vulvar Neoplasms, Desmoid Tumors, Seminoma, Carcinoma, Acinar Cell, Adrenocortical Carcinoma, Carcinoma, Endometrioid, Cholangiocarcinoma, Cystadenocarcinoma, Mucinous, Cystadenocarcinoma, Serous, Carcinoma, Giant Cell, Neurofibrosarcoma, Gestational Trophoblastic Disease, Rare Diseases, Gastrointestinal Stromal Tumors, Perivascular Epithelioid Cell Neoplasms

NCT04087902 2026-05-20

Long-Term Longitudinal QoL in Patients Undergoing EEA

Ohio State University

Active not recruiting
400 enrolled
CNSEndocrineSarcoma

Chondrosarcoma, Chordoma, Craniopharyngioma, Encephalocele, Meningioma, Pituitary Neoplasms, Esthesioneuroblastoma, Olfactory, Central Nervous System Cysts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡